Phenotyping of atrial fibrillation with cluster analysis and external validation

Author:

Saito YukiORCID,Omae Yuto,Nagashima Koichi,Miyauchi Katsumi,Nishizaki Yuji,Miyazaki Sakiko,Hayashi Hidemori,Nojiri Shuko,Daida Hiroyuki,Minamino Tohru,Okumura Yasuo

Abstract

ObjectivesAtrial fibrillation (AF) is a heterogeneous condition. We performed a cluster analysis in a cohort of patients with AF and assessed the prognostic implication of the identified cluster phenotypes.MethodsWe used two multicentre, prospective, observational registries of AF: the SAKURA AF registry (Real World Survey of Atrial Fibrillation Patients Treated with Warfarin and Non-vitamin K Antagonist Oral Anticoagulants) (n=3055, derivation cohort) and the RAFFINE registry (Registry of Japanese Patients with Atrial Fibrillation Focused on anticoagulant therapy in New Era) (n=3852, validation cohort). Cluster analysis was performed by the K-prototype method with 14 clinical variables. The endpoints were all-cause mortality and composite cardiovascular events.ResultsThe analysis subclassified derivation cohort patients into five clusters. Cluster 1 (n=414, 13.6%) was characterised by younger men with a low prevalence of comorbidities; cluster 2 (n=1003, 32.8%) by a high prevalence of hypertension; cluster 3 (n=517, 16.9%) by older patients without hypertension; cluster 4 (n=652, 21.3%) by the oldest patients, who were mainly female and with a high prevalence of heart failure history; and cluster 5 (n=469, 15.3%) by older patients with high prevalence of diabetes and ischaemic heart disease. During follow-up, the risk of all-cause mortality and composite cardiovascular events increased across clusters (log-rank p<0.001, p<0.001). Similar results were found in the external validation cohort.ConclusionsMachine learning-based cluster analysis identified five different phenotypes of AF with unique clinical characteristics and different clinical outcomes. The use of these phenotypes may help identify high-risk patients with AF.

Funder

PARAMOUNT BED HOLDINGS CO., LTD.

Resmed Japan

Eisai Co., Ltd, Bayer Yakuhin, Ltd

Philips Japan Inc., FUJIFILM Holdings Corporation, Asahi Kasei Corp., Inter Reha Co. Ltd, Toho Holdings Co. Ltd

Bayer Yakuhin, Ltd

Medtronic Japan

Boston Scientific Japan, Abbott

Bayer Healthcare, Daiichi-Sankyo, Bristol

Bayer Healthcare, Daiichi-Sankyo

Fukuda Denshi Co. Ltd

Nippon Boehringer Ingelheim, Pfizer Japan

Squibb

Novartis Pharma

Boston Scientific Japan

Philips Japan Inc.

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3